Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Modernatx, Inc.

Clinical trials sponsored by Modernatx, Inc., explained in plain language.

Trials to join now! 12 Not yet finished but already full! 13 Completed 13 Terminated 2

Moderna's mRNA tech targets common, dangerous virus in major trial

⭐️ VACCINE ⭐️ Terminated

This was a large, late-stage study testing whether Moderna's mRNA-1647 vaccine could safely prevent initial infection with cytomegalovirus (CMV), a common virus that can cause serious health problems for newborns and people with weakened immune systems. It enrolled over 7,400 hea…

Phase: PHASE3 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 27, 2026 12:40 UTC
Moderna infant COVID vaccine trial halted early

⭐️ VACCINE ⭐️ Terminated

This study aimed to test the safety and effectiveness of Moderna's updated COVID-19 vaccine (mRNA-1273.214) in very young infants, aged 12 weeks to under 6 months. It planned to compare the babies' immune responses to those seen in adults from a previous study. However, the trial…

Phase: PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 16, 2026 15:23 UTC